Melfa Fabrizio, McCarthy Alec, Aguilera Shino Bay, van Loghem Jani, Gennai Alessandro
Mediaging Clinic Center, 90143 Palermo, Italy.
Merz Aesthetics, Raleigh, NC 27615, USA.
J Clin Med. 2024 Jul 26;13(15):4381. doi: 10.3390/jcm13154381.
: This retrospective observational study sought to determine the efficacy and safety of an innovative combined treatment protocol using guided Superficial Enhanced Fluid Fat Injection (SEFFI) and calcium hydroxylapatite (CaHA) in facial rejuvenation. : A total of 158 patients (149 females and 9 males) underwent the combined treatment of guided SEFFI and diluted/hyperdiluted CaHA. The study evaluated treatment outcomes at 30, 90, and 150 days post-treatment using the Global Aesthetic Improvement Scale (GAIS) and three-dimensional photogrammetric analysis. : The combined treatment demonstrated consistent enhancement in skin quality and facial volume across temporal, malar, zygomatic, and jawline regions. At 90 days post-treatment, substantial improvements were observed, with the GAIS scores reflecting significant enhancements in both skin quality and volume, which were sustained or slightly improved by 150 days. Minor complications, predominantly ecchymosis at the injection sites, resolved within a week, confirming the treatments' safety. : The integration of guided SEFFI and CaHA resulted in significant improvements in skin quality and facial volume with minimal complications. Further research is recommended to consolidate these findings and explore long-term outcomes.
这项回顾性观察研究旨在确定一种创新的联合治疗方案——引导式浅表强化脂肪注射液(SEFFI)与羟基磷灰石(CaHA)联合用于面部年轻化的疗效和安全性。
共有158例患者(149例女性和9例男性)接受了引导式SEFFI与稀释/超稀释CaHA的联合治疗。该研究使用全球美学改善量表(GAIS)和三维摄影测量分析评估了治疗后30天、90天和150天的治疗效果。
联合治疗在颞部、颧部、颧骨和下颌缘区域的皮肤质量和面部容积方面均表现出持续改善。治疗后90天,观察到显著改善,GAIS评分显示皮肤质量和容积均有显著提高,到150天时保持稳定或略有改善。轻微并发症主要为注射部位瘀斑,一周内消退,证实了治疗的安全性。
引导式SEFFI与CaHA的联合使用在皮肤质量和面部容积方面取得了显著改善,并发症极少。建议进一步开展研究以巩固这些发现并探索长期疗效。